NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced its investigational novel COVID-19 oral antiviral candidate, PAXLOVID™, significantly reduced hospitalization and death, based on an ...
University of Virginia School of Medicine researchers Xiaoqin Wei, PhD, and Jie Sun, PhD, have made a COVID-19 discovery that could open the door to new treatments for the lingering effects of not ...
Fintel reports that on December 22, 2025, LifeSci Capital initiated coverage of Ovid Therapeutics (NasdaqCM:OVID) with a Outperform recommendation. As of December 21, 2025, the average one-year price ...
Fintel reports that on December 22, 2025, HC Wainwright & Co. reiterated coverage of Ovid Therapeutics (NasdaqCM:OVID) with a Buy recommendation. As of December 21, 2025, the average one-year price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results